30 September - 2 October 2026

10th SCI-RSC Symposium on GPCRs in Medicinal Chemistry

Organised by:

SCI’s Fine Chemicals group and RSC’s Biological & Medicinal Chemistry group

Evotec, Verona, Italy

Register for this event
Synopsis
The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to hold this 10th meeting in the series on GPCR drug discovery, which combines cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

The meeting will consist of:

• Case studies in GPCR drug discovery and development
• Structural biology advances and impact on drug design
 

Attendees
The meeting will consist of:

• Case studies in GPCR drug discovery and development
• Structural biology advances and impact on drug design
• Showcasing multiple modalities and drug discovery approaches to modulating GPCRs
 

Programme

To view the full programme, see the link


Call for abstracts
For further information and to submit, see the link

 


Exhibition and sponsorship
For further information and to book, see the link


Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.


Venue and Contact

Evotec

Evotec Campus Levi-Montalcini, Verona, Italy

For further information on the venue see the link

Hg3 Conferences Ltd

Tel: +44 (0)1423529333

Email: events@hg3.co.uk


Fees
To see the delegate fees and to register see the link

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Bursaries
For further information see the link
Partners

Organising Committee
Andrew Williams, RSC BMCS
Adrian Hall, UCB
Angela Russell, University of Oxford
Caroline Low, Isomorphic Labs
Daniel Jones, Nxera Pharma
Fraser Cunningham, Recursion
Susanna Cremonesi, Evotec